logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Respiratory illness, bêta-agonists, and risk of idiopathic dilated cardiomyopathy : the Washington, DC, dilated cardiomyopathy study.

    Article - En anglais

    An epidemiologic study was carried out to examine the possible role of bêta-agonists and other respiratory medications in the development of idiopathic dilated cardiomyopathy.

    Associations with respiratory medications, bronchial asthma, emphysema, and chronic bronchitis were examined by comparing newly diagnosed cases (n=129) ascertained from five Washington, DC, area hospitals for the period 1990-1992 with neighborhood controls (n=258) identified by using a random digit dialing technique.

    The cases and controls were matched on sex and 5-year age intervals and were compared in the analysis using conditional logistic regression methods.

    A statistically significant association was observed between idiopathic dilated cardiomyopathy and history of emphysema or chronic bronchitis (adjusted odds ratio (OR)=4.4,95% confidence interval (01) 1.6-12.4).

    The association with bronchial asthma was of borderline significance (adjusted OR=1.9,95% Cl 0.9-4.2).

    Associations were also observed with use of oral bêta-agonists (adjusted OR=3.4,95% CI 1.1-11.0) and bêta-agonist inhalers or nebulization (adjusted OR=3.2,95% CI 1.4-7.1), as well as with use of oral corticosteroids, inhaled corticosteroids or cromolyn, and theophylline medications.

    The results of this study suggest, but do not prove, that use of bêta-agonists has an etiologic role in idiopathic dilated cardiomyopathy.

    Am J Epidemiol 1995 ; 142 : 395-403.

    Mots-clés Pascal : Cardiomyopathie, Idiopathique, Epidémiologie, Toxicité, Agoniste, Récepteur bêta-adrénergique, Bronchodilatateur, Appareil respiratoire pathologie, Association, Homme, Chimiothérapie, Traitement, Etats Unis, Amérique du Nord, Amérique, Appareil circulatoire pathologie, Cardiopathie, Myocarde pathologie

    Mots-clés Pascal anglais : Cardiomyopathy, Idiopathic, Epidemiology, Toxicity, Agonist, bêta-Adrenergic receptor, Bronchodilator, Respiratory disease, Association, Human, Chemotherapy, Treatment, United States, North America, America, Cardiovascular disease, Heart disease, Myocardial disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0487617

    Code Inist : 002B02U07. Création : 01/03/1996.